Abbreviated New Drug Application

An abbreviated new drug application is an application to the FDA for a pharmaceutical company to produce a generic version of an existing licensed medication or approved drug.

Case Study

Geriatric Neurology Expert in Cerebral Ischemia

A geriatric neurology expert in cerebral ischemia was needed for a patent infringement case.

Case Study

Forensic Pharmacologist to Review Composition of Generic Analgesic

A forensic pharmacologist was needed for a pharmaceutical industry patent infringement case involving an Abbreviated New Drug application (ANDA) with the Food and Drug Administration (FDA) to market a generic form of an analgesic.

Case Study

Wasting Syndrome Expert in Cachexia Treatment Drugs

A wasting syndrome expert was requested for a patent infringement suit involving cachexia treatment drugs.